Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Drug Formulary

About the Drug Formulary Email Drug Formulary Team

Funded Evidence-Informed Regimens

Drug and regimen monographs and information sheets for patients provide information on dosing and administering cancer treatment protocols. They are for general reference and are not meant to replace prescribing information or physician recommendations.

If you have questions about ST-QBP funding on our website, please visit our Frequently Asked Questions page.

Find enhanced Regimen Patient Information Sheets, created in collaboration with patient and family advisors.

Regimens

Filtered By:

8 Items

AMSAATRACYTA

Cancer Type: Hematologic, Leukemia - Acute Promyelocytic (APL)
Intent: Curative

Drugs Used:

amsacrine,

cytarabine,

tretinoin (ATRA) (Unfunded)

... Show more tags

Quick Link(s):

Regimen Monograph

May 2019

AMSACYTA

Cancer Type: Hematologic, Leukemia - Acute Myeloid (AML)
Intent: Curative

Drugs Used:

amsacrine,

cytarabine

... Show more tags

Quick Link(s):

Regimen Monograph

May 2019

BEP(5D)PACL

Cancer Type: Gynecologic, Germ Cell
Intent: Curative

Drugs Used:

Quick Link(s):

Regimen Monograph

May 2019

BEP(5D)PACL

Cancer Type: Genitourinary, Testis
Intent: Curative

Drugs Used:

Quick Link(s):

Regimen Monograph

May 2019

CRBPPACL+BEVA

Cancer Type: Gynecologic, Ovary
Intent: Palliative, Curative

Funding:

New Drug Funding Program

Bevacizumab (Biosimilar) with Paclitaxel and Carboplatin - Front-line Treatment (Previously Untreated) Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Aug 2019